Search Results 1161-1170 of 17217 for Protozoa
Mayo Clinic's John R. Hawse IV, Ph.D., studies hormone receptors in normal and diseased tissues, characterizes drivers of breast and ovarian cancers, ...
Progress in gene therapy offers hope for long-term knee pain relief. Mayo Clinic researchers aim to engineer knees that are more resistant to arthritis.
The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with recurrent ...
Mayo Clinic Radio: Artificial intelligence to detect heart failure / migraine drugs / adult ADHD · Expert Alert: Mayo Clinic aerospace medicine experts look ...
This is a phase 1, open-label, multicenter, ascending-dose escalation study of REGN2810, alone and in combination with other anti-cancer therapies in patients ...
Mayo Clinic's Proteomics Core provides investigators with technologies and services to analyze proteins from tissues, cells or biological samples.
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
Dr. Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. Cardiovascular risks ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Areas of study have included: Leading a multicenter, multinational trial to compare drug therapy with cardiac ablation for people with heart rhythm disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.